Literature DB >> 19827750

Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1).

Irena Berezowska1, Nga N Chung, Carole Lemieux, Brian C Wilkes, Peter W Schiller.   

Abstract

The novel phenylalanine analogues 4'-[N-((4'-phenyl)phenethyl)carboxamido]phenylalanine (Bcp) and 2',6'-dimethyl-4'-[N-((4'-phenyl)phenethyl)carboxamido]phenylalanine (Dbcp) were substituted for Tyr(1) in the delta opioid antagonist TIPP (H-Tyr-Tic-Phe-Phe-OH; Tic = tetrahydroisoquinoline-3-carboxylic acid). Unexpectedly, [Bcp(1)]TIPP was a potent, selective delta opioid agonist, whereas [Dbcp(1)]TIPP retained high delta antagonist activity. Receptor docking studies indicated similar binding modes for the two peptides except for the biphenylethyl moiety which occupied distinct receptor subsites. The dipeptide H-Dbcp-Tic-OH was a highly selective delta antagonist with subnanomolar delta receptor affinity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19827750      PMCID: PMC2783503          DOI: 10.1021/jm9004913

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

Review 1.  Structure-activity relationships of enkephalin-like peptides.

Authors:  J S Morley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

Review 2.  The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.

Authors:  P W Schiller; G Weltrowska; I Berezowska; T M Nguyen; B C Wilkes; C Lemieux; N N Chung
Journal:  Biopolymers       Date:  1999       Impact factor: 2.505

3.  Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.

Authors:  P W Schiller; T M Nguyen; G Weltrowska; B C Wilkes; B J Marsden; C Lemieux; N N Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

4.  TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.

Authors:  P W Schiller; G Weltrowska; T M Nguyen; B C Wilkes; N N Chung; C Lemieux
Journal:  J Med Chem       Date:  1993-10-15       Impact factor: 7.446

5.  Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.

Authors:  S Salvadori; M Attila; G Balboni; C Bianchi; S D Bryant; O Crescenzi; R Guerrini; D Picone; T Tancredi; P A Temussi
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

6.  (4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligands.

Authors:  Roland E Dolle; Mathieu Machaut; Blanca Martinez-Teipel; Serge Belanger; Joel A Cassel; Gabriel J Stabley; Thomas M Graczyk; Robert N DeHaven
Journal:  Bioorg Med Chem Lett       Date:  2004-07-05       Impact factor: 2.823

7.  Potent opioid peptide agonists containing 4'-[N-((4'-phenyl)-phenethyl)carboxamido]phenylalanine (Bcp) in place of Tyr.

Authors:  Grazyna Weltrowska; Thi M-D Nguyen; Carole Lemieux; Nga N Chung; Peter W Schiller
Journal:  Chem Biol Drug Des       Date:  2008-11       Impact factor: 2.817

8.  Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin.

Authors:  D W Hansen; A Stapelfeld; M A Savage; M Reichman; D L Hammond; R C Haaseth; H I Mosberg
Journal:  J Med Chem       Date:  1992-02-21       Impact factor: 7.446

9.  Solid phase synthesis of peptides containing the CH2NH peptide bond isostere.

Authors:  Y Sasaki; D H Coy
Journal:  Peptides       Date:  1987 Jan-Feb       Impact factor: 3.750

10.  trans-3,4-dimethyl-4-(3-carboxamidophenyl)piperidines: a novel class of micro-selective opioid antagonists.

Authors:  Bertrand Le Bourdonnec; Serge Belanger; Joel A Cassel; Gabriel J Stabley; Robert N DeHaven; Roland E Dolle
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

View more
  8 in total

1.  Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.

Authors:  Jinguo Ding; Carole Lemieux; Nga N Chung; Peter W Schiller
Journal:  Chem Biol Drug Des       Date:  2012-01-04       Impact factor: 2.817

2.  Selection of DNA-Encoded Libraries to Protein Targets within and on Living Cells.

Authors:  Bo Cai; Dongwook Kim; Saeed Akhand; Yixing Sun; Robert J Cassell; Aktan Alpsoy; Emily C Dykhuizen; Richard M Van Rijn; Michael K Wendt; Casey J Krusemark
Journal:  J Am Chem Soc       Date:  2019-10-22       Impact factor: 15.419

Review 3.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  New approaches towards the synthesis of 1,2,3,4-tetrahydro isoquinoline-3-phosphonic acid (TicP).

Authors:  José Luis Viveros-Ceballos; Lizeth A Matías-Valdez; Francisco J Sayago; Carlos Cativiela; Mario Ordóñez
Journal:  Amino Acids       Date:  2021-03-01       Impact factor: 3.520

5.  Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.

Authors:  John L Neumeyer; Bin Zhang; Tangzhi Zhang; Anna W Sromek; Brian I Knapp; Dana J Cohen; Jean M Bidlack
Journal:  J Med Chem       Date:  2012-04-04       Impact factor: 7.446

6.  Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the δ opioid receptor. Discovery of two highly potent and selective δ opioid agonists.

Authors:  Irena Berezowska; Carole Lemieux; Nga N Chung; Jinguo Ding; Peter W Schiller
Journal:  Bioorg Med Chem Lett       Date:  2012-01-28       Impact factor: 2.823

7.  Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds.

Authors:  Gianfranco Balboni; Erika Marzola; Yusuke Sasaki; Akihiro Ambo; Ewa D Marczak; Lawrence H Lazarus; Severo Salvadori
Journal:  Bioorg Med Chem       Date:  2010-06-25       Impact factor: 3.641

8.  In Vitro Membrane Permeation Studies and in Vivo Antinociception of Glycosylated Dmt1-DALDA Analogues.

Authors:  Steven Ballet; Cecilia Betti; Alexandre Novoa; Csaba Tömböly; Carsten Uhd Nielsen; Hans Christian Helms; Anna Lesniak; Patrycja Kleczkowska; Nga N Chung; Andrzej W Lipkowski; Birger Brodin; Dirk Tourwé; Peter W Schiller
Journal:  ACS Med Chem Lett       Date:  2014-04-10       Impact factor: 4.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.